NI+

Catching up with weight loss companion supplements: A roundup of the latest science

Couple in the park having break and eating healthy meal. Salad and apple. Focus is on woman.
Much of the latest weight management research centers on microbiome-targeted ingredients that may enhance satiety, reduce adiposity and help prevent weight regain. (Getty Images)

Rising global obesity rates and the challenge of maintaining weight loss after GLP-1 treatment are driving a new wave of research into how functional ingredients may support sustainable weight management.

While supplements and traditional OTC ‘diet pills’ in the category have often relied on stimulants, laxatives and other short-term mechanisms, the latest generation of supplements is drawing on functional ingredients being investigated for their potential to influence appetite, gut health, hormonal signaling and glucose regulation.

More recently, clinical research has also placed greater emphasis on body composition as an indicator of weight-management success, exploring ways to target fat mass reduction while helping preserve lean muscle. Microbiome modulation has attracted growing scientific interest, with studies investigating how specific probiotics, prebiotics and other functional ingredients may influence metabolic health and weight regulation.

Although most of the effects observed are modest, these ingredients are not designed to replace GLP-1 therapies but work alongside healthy diet and exercise routines to support weight management.

Kimere-derived probiotics may offer modest weight loss benefits

Supplementation with Kimere-derived probiotics may provide weight loss benefits when taken alongside a lifestyle-based weight management program, according to research published in Nutrients.

Scientists from Texas A&M University tested the probiotic combination (supplied by Austria-based probiotic company Slimbiotics) in 77 overweight adults with an average age of 35. Half the participants took the combination of Limosilactobacillus fermentum K7-Lb1, L. fermentum K8-Lb1 and L. fermentum K11-Lb3 and the other half were given a placebo product. Both groups also completed a 12-week weight loss program where they consumed a 500 kcal/day energy deficit diet and walked 10,000 steps per day.

Explore related questions

Overall, probiotic supplementation was associated with numerically greater reductions in fat mass, body fat percentage and measures of central adiposity than placebo. In total, the probiotic group lost an average of 2.7 kg more fat than the placebo group.

However, many between-group differences did not reach statistical significance. Despite this, co-founder of Slimbiotics Helmut Essl described the results as “exceptionally encouraging.”

“Together with our two previously published studies, we now have a robust and growing body of clinical evidence demonstrating significant, meaningful outcomes in weight management and metabolic health,” he previously told NutraIngredients. “These are not incremental findings. They reinforce our conviction that the SlimBiotics strains represent a true breakthrough in this space.”

Kimere-derived probiotics may offer modest weight loss benefits
Opens in new window

Synbiotic may reduce body fat and improve metabolic health markers

A synbiotic containing Bifidobacterium longum, Bifidobacterium animalis, lychee polyphenols, prebiotics and postbiotics may reduce body fat and improve metabolic health markers, according to new research.

Published in the Journal of Functional Foods, the five-week pilot study was conducted to understand the synbiotic’s effect on body composition, metabolic markers, gut microbiota-derived metabolites and GLP-1 secretion.

Researchers from Leeuwenhoek Laboratories Co. Ltd, Taiwan, who developed the synbiotic marketed as Flora Le Light, recruited 58 adults in total. All participants were instructed to take the synbiotic product daily, with body composition, glucose metabolism, lipid metabolism, insulin sensitivity and gut microbiome metabolites measured at the beginning and end of the trial period.

After 35 days, significant reductions in body weight, fat mass, body fat percentage and visceral fat were observed, with average body weight decreasing by 1.27 kg. Several metabolic markers also improved, including HbA1c, fasting insulin and HOMA-IR.

The authors suggested that improvements in adiposity and metabolic health may be mediated through changes in gut microbiota-derived metabolites and enhanced GLP-1 secretion. However, they noted that the study was a short-term, single-arm pilot trial without a placebo control group, limiting the strength of the conclusions.

“These results suggest that this synbiotic could be a novel approach to enhance metabolic health and alleviate obesity by modulating gut microbiota-derived metabolites and incretin hormones,” they wrote. “More long-term and detailed studies are necessary to better understand the mechanisms and improve clinical applications.”

Hop-derived ingredient may help overweight adults lose body fat while maintaining muscle mass

Calocurb, a hop-derived product commercialized by New Zealand company Calocurb Ltd., has been shown to help overweight adults lose body fat in a recent clinical trial.

CaloCurb contains Amarasate, a patented extract derived from New Zealand-grown hops flowers, as well as rosemary leaf extract and rapeseed oil. Previous research has shown it may reduce hunger and calorie intake, but the latest study published in Obesity Pillars is the first to show how these effects translate into measurable improvements in body composition.

To conduct the study, 150 overweight adult participants from New Zealand were randomized to receive either Calocurb or a placebo for 24 weeks. Participants also attended monthly dietitian-led sessions covering healthy eating and physical activity.

By the end of the trial period, the intervention group lost an average of 3.8 kg, while the placebo group lost, on average, 0.4 kg. The Calocurb group also experienced greater reductions in visceral fat, with no indication of overall muscle loss.

“These findings contribute to a growing body of work supporting the use of BHEs [bitter hop extract] for weight management, further supporting this BHE as an adjunct therapy during weight loss interventions, and additionally shows that longer term BHE treatment results in decreased hunger and food cravings that are maintained for the duration of the treatment and that are unlikely to be related to any GI side effects experienced,” the researchers concluded.

Hop extract study moves beyond appetite to body composition
Opens in new window

Probiotic may lower BMI and speed up fat loss in obese children

A strain of Bifidobacterium animalis subsp. Lactis has been shown to support childhood weight management and improve metabolic markers in an ‘exploratory’ study published in npj Biofilms and Microbiomes.

ProSci-246, commercialized by Chinese biotechnology firm Scitop Bio, was shown to reduce BMI and fat loss faster than placebo in a three-month RCT involving 95 children with obesity. The children were randomized to receive either 20 billion CFU/day of ProSci-246 or placebo, with both groups receiving personalized dietary guidance.

The researchers from Inner Mongolia Agricultural University, Inner Mongolia People’s Hospital and collaborating institutions reported that ProSci-246 reshaped the gut microbiota, increasing levels of beneficial species while reducing several taxa associated with obesity-related metabolic dysfunction.

However, the authors noted that many findings became weaker after correction for multiple comparisons. The study also combined probiotic supplementation with dietary counseling, making it difficult to isolate the independent effect of the probiotic.

“In summary, while our findings provide valuable insights, they should be interpreted as exploratory and hypothesis-generating,” they concluded. “Further studies with comprehensive dietary monitoring, ITT analysis, complete data collection, and robust multi-omics validation are needed to substantiate and extend these results.”

Capsaicin may improve body composition measures

Supplementation with Capsifen, an encapsulated capsaicin ingredient from Akay Bioactives, may improve body composition measures in overweight and obese older adults, according to research published in Nutrients.

Researchers from the University of Southern Queensland conducted a 12-week randomized, placebo-controlled trial involving 34 adults aged 50 to 80 with a BMI of at least 25 kg/m². Participants received either 200 mg/day of Capsifen or a placebo and underwent a range of anthropometric, cardiovascular and cognitive assessments before and after the intervention.

While the study primarily investigated cerebrovascular function and cognition, Capsifen supplementation was also associated with reductions in waist circumference and waist-to-hip ratio compared with placebo. The researchers suggested these findings align with previous evidence indicating that capsaicin may help reduce adiposity through effects on energy metabolism, inflammation and vascular function.

The researchers cautioned that the anthropometric findings should be interpreted carefully due to the small sample size and exploratory nature of the trial. They concluded that larger and longer-term studies are needed to confirm whether Capsifen can meaningfully support weight management in overweight and obese adults.

Capsaicin may improve cognition and reduce waist-to-hip metrics
Opens in new window

Probiotics, enzyme and botanical combo may support weight loss and metabolic health

Supplementation with SlimSEB, a blend of probiotics, enzymes and botanical extracts from Specialty Enzymes & Probiotics, may support weight loss and metabolic health in overweight and obese adults at risk of type 2 diabetes, according to a study published in Frontiers in Nutrition.

T he 84-day randomized, double-blind, placebo-controlled trial included 87 overweight or obese adults who were randomized to receive either SlimSEB, containing 1.5 billion CFU of probiotics alongside digestive enzymes, mulberry leaf extract, green tea, cinnamon powder and chromium picolinate, or a placebo.

Compared with placebo, SlimSEB supplementation led to significantly greater reductions in body weight, BMI and waist circumference. Overweight participants lost an additional 2.6 kg and obese participants an additional 4.5 kg versus placebo. Significant improvements were also observed for fasting plasma glucose, HbA1c, insulin resistance (HOMA-IR) and total cholesterol.

The researchers from Advanced Enzymes Technologies suggested the observed benefits may result from complementary effects of the probiotic, enzyme and botanical components on gut microbiota, glucose metabolism and adiposity but called for larger clinical trials to confirm the findings and clarify the underlying mechanisms.

Probiotic strain may reduce body weight and adiposity

Supplementation with the probiotic Lactiplantibacillus plantarum J26 may support modest reductions in body weight and adiposity in adults with metabolic syndrome, according to research published in npj Science of Food.

Researchers from Sun Yat-sen University and Zhongshan City People’s Hospital tested the strain in a 12-week randomized, double-blind, placebo-controlled trial involving 110 adults aged 40 to 65 with metabolic syndrome. Participants received either a daily capsule containing 5 billion CFU of L. plantarum J26 or a placebo.

Compared with placebo, probiotic supplementation led to significant reductions in body weight, BMI, waist circumference and body fat percentage. Participants taking the probiotic lost an average of 0.97 kg, representing a net difference of 0.75 kg compared with placebo. Waist circumference decreased by 1.92 cm, body fat by 0.87% and BMI by 0.29 kg/m².

Participants in the intervention arm also saw improvements in triglycerides, total cholesterol and LDL-cholesterol, but none of the between-group differences reached statistical significance. In addition, no significant effects were observed for glycemic markers, insulin resistance or blood pressure.

The intervention also increased levels of Lactobacillus and Bifidobacterium, with mediation analyses suggesting these microbiome changes accounted for a substantial proportion of the improvements in body weight and BMI. The researchers indicated that higher baseline diet quality and gut microbiota differences may help explain why some individuals responded more strongly to supplementation than others.

L. plantarum intake lowers body weight and BMI
Opens in new window

Bifidobacterium lactis may reduce body fat in overweight and obese adults

Research published in the Journal of Functional Foods suggests that a specific strain of B. lactis may reduce total body fat mass in adults who are overweight or obese.

The strain (B. lactis IDCC 4301), marketed as B. lactis Fit, is developed and commercialized by Ildong Bioscience, a South Korean biotechnology company, which funded the study.

To test the efficacy of the strain, researchers from the company and Kyung Hee University conducted a 12-week randomized, double-blind, placebo-controlled trial involving 100 Korean adults with a BMI of 25.0–29.9 kg/m². Participants received either the probiotic or a placebo while maintaining their usual diet and physical activity.

By the end of the trial, DEXA-measured total body fat mass reduced in the intervention group and increased in the placebo arm, resulting in a between-group difference of 1.86 kg. Significant improvements were also observed for total body fat percentage, trunk fat mass and other regional fat measures. The probiotic was well tolerated, with no product-related adverse events or serious safety concerns reported.

“These findings may support B. lactis IDCC 4301 as a candidate functional probiotic for body fat management in adults with overweight or obesity,” the authors concluded.

High-fiber tapioca pearls may reduce body weight, fat mass and LDL cholesterol

Taiwanese researchers published findings from a clinical trial evaluating the effects of a high-fiber tapioca pearl, designed to be incorporated as a functional ingredient in bubble tea.

Originating in Taiwan in the 1980s, bubble tea has become a worldwide social and cultural phenomenon. Tapioca pearls (or boba), traditionally made from cassava starch, are central to this beverage’s appeal, but they are calorie dense and offer little nutritional value. Researchers from Chung Shan Medical University therefore set out to create an alternative, incorporating inulin to provide fiber and offer potential weight management properties.

To test the efficacy of I-fiber pearl, commercialized by Ying-Hui Biotechnology Co Ltd, the researchers conducted a 12-week randomized, double-blind, placebo-controlled trial involving 50 women with obesity or central adiposity. Participants consumed either I-fiber pearl, providing approximately 8 g of chicory inulin or a placebo formulation.

Compared with placebo, I-fiber pearl supplementation led to significantly greater reductions in body weight, with the intervention group losing an average of 1.97 kg over 12 weeks, compared with 0.42 kg in the placebo group. BMI, body fat mass, visceral fat levels, total cholesterol and LDL cholesterol also decreased.

The researchers suggested that the benefits may stem from the prebiotic effects of chicory inulin, which has previously been linked to improved satiety, reduced fat accumulation and favorable alterations in gut-derived metabolites.

“In conclusion, these findings suggest that I-fiber pearl supplementation for 12 weeks can effectively improve body composition and lipid metabolism in obese individuals,” the researchers wrote in the Journal of Food and Drug Analysis. “Therefore, I-fiber pearl may serve as a promising dietary supplement for reducing body fat accumulation and supporting obesity management.”

Akkermansia may support weight loss maintenance

Akkermansia muciniphila (MucT) is increasingly being studied for weight management, with recent research exploring whether it may help prevent weight regain following a period of weight loss.

Published in Nature Medicine, the study evaluated whether MucT could help prevent weight regain alongside a healthy diet after an eight-week weight loss program. In total, 90 overweight and obese adults followed a low energy diet for 56 days and were then randomized to consumer either MucT or placebo for 24 weeks.

Researchers from Maastricht University Medical Center and collaborators reported that participants receiving MucT regained significantly less weight—on average, 1.2 kg compared with 3.2 kg in the placebo group. Across the entire 32-week trial, the intervention arm lost an average of 10.3 kg, while the placebo group lost an average of 7.3 kg.

Supplementation with Akkermansia MucT was also associated with better preservation of insulin sensitivity and improved fasting glucose. However, no significant between-group differences were observed for blood lipids, inflammatory markers, GLP-1 levels or overall gut microbiota composition. Even so, the authors concluded that the findings may be relevant for GLP-1 users.

“Pasteurized A. muciniphila MucT supplementation could represent a promising strategy for long-term weight management after energy restriction or GLP-1 receptor agonist use,” they wrote.

Oat bran may help to prevent weight regain post-bariatric surgery

Supplementation with an oat bran-derived dietary fiber may enhance satiety and improve metabolic health in patients recovering from bariatric surgery, according to research published in Nutrition.

Researchers from the First Affiliated Hospital of Soochow University conducted a 12-week randomized controlled trial involving 63 adults who were six months post-bariatric surgery. Participants received either standard postoperative care or standard care plus 30 g/day of oat bran, providing approximately nine grams of dietary fiber.

Compared with the placebo group, participants in the intervention arm experienced favorable shifts in gut microbiota composition and had significant increases in two satiety hormones, GLP-1 and PYY. Those supplementing with the oat-bran fiber also had lower fasting blood glucose and higher HDL cholesterol levels than controls, suggesting benefits for glucose regulation and lipid metabolism.

While the intervention group achieved numerically greater excess weight loss than controls, the between-group difference did not reach statistical significance. Despite this, the authors suggest that since both groups continued to lose weight over the study period, dietary fiber could help support weight loss maintenance during the critical period when postoperative weight loss begins to slow.

“Based on our findings, we recommend an appropriate increase in DF [dietary fiber] intake for patients in the stable dietary phase after BS [bariatric surgery], as this may help prevent postoperative weight regain,” they wrote. “DF supplementation (oat bran) represents a simple, effective, and cost-efficient non-pharmacological adjunct for metabolic management in post-BS patients during the dietary stabilization phase.”

What the science suggests

  • Gut health is becoming central to weight management, with probiotics, synbiotics, prebiotics and postbiotics increasingly linked to improvements in body composition and metabolic health.
  • Researchers are targeting satiety pathways rather than rapid weight loss, particularly by increasing GLP-1 and PYY signaling to help regulate appetite and food intake.
  • Preventing weight regain is emerging as a major focus, with ingredients such as Akkermansia muciniphila and dietary fiber showing potential to support long-term weight maintenance.
  • Body composition is taking precedence over body weight, with many studies reporting reductions in visceral fat, waist circumference and body fat mass while preserving lean muscle.
  • Weight management ingredients are most effective as adjuncts to lifestyle interventions, complementing existing healthy lifestyle routines.